Chargement en cours...
Medullary Thyroid Cancer in the Era of Tyrosine Kinase Inhibitors: To Treat or Not to Treat—and With Which Drug—Those Are the Questions
CONTEXT: Medullary thyroid cancer (MTC) is a rare form of thyroid cancer comprising approximately 4% of all thyroid cancers. The majority of patients have a relatively good prognosis; however, a subgroup of patients will require systemic therapy. Large phase III randomized trials led to the approval...
Enregistré dans:
| Publié dans: | J Clin Endocrinol Metab |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Endocrine Society
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4255127/ https://ncbi.nlm.nih.gov/pubmed/25238206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2811 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|